Clinical Trial Update: Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME") [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update (RIME) evaluating buprenorphine/naloxone for reducing intravenous buprenorphine misuse in France among individuals with opioid dep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Dependency | Phase 4 | Status: COMPLETED